Literature DB >> 26311226

Robotic adrenalectomy: the jury is still out.

Mark W Ball1, Mohamad E Allaf1.   

Abstract

A minimally-invasive approach is the gold standard for surgical management of the majority of adrenal masses. While laparoscopy has traditionally been used, robotic adrenalectomy is becoming increasingly utilized. This article discusses a recent systematic review and meta-analysis from European Urology that analyzed evidence comparing laparoscopic and robotic adrenalectomy. Robotic adrenalectomy is associated with lower blood loss, length of stay and fewer complications compared to laparoscopic adrenalectomy; however information on efficacy and cost are not addressed. Ultimately, well-done randomized controlled trials (RCTs) are necessary to determine the benefits and cost of robotics in adrenal surgery.

Entities:  

Keywords:  Adrenalectomy; laparoscopy; robotics

Year:  2015        PMID: 26311226      PMCID: PMC4523635          DOI: 10.3978/j.issn.2227-684X.2015.04.16

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  15 in total

1.  Robotic versus laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Shamil Aliyev; Koray Karabulut; Orhan Agcaoglu; Katherine Wolf; Jamie Mitchell; Allan Siperstein; Eren Berber
Journal:  Ann Surg Oncol       Date:  2013-07-18       Impact factor: 5.344

Review 2.  Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis.

Authors:  Luis Felipe Brandao; Riccardo Autorino; Humberto Laydner; Georges-Pascal Haber; Idir Ouzaid; Marco De Sio; Sisto Perdonà; Robert J Stein; Francesco Porpiglia; Jihad H Kaouk
Journal:  Eur Urol       Date:  2013-09-20       Impact factor: 20.096

3.  Robotic vs laparoscopic posterior retroperitoneal adrenalectomy.

Authors:  Orhan Agcaoglu; Shamil Aliyev; Koray Karabulut; Allan Siperstein; Eren Berber
Journal:  Arch Surg       Date:  2012-03

4.  Robotic versus laparoscopic resection of large adrenal tumors.

Authors:  Orhan Agcaoglu; Shamil Aliyev; Koray Karabulut; Jamie Mitchell; Allan Siperstein; Eren Berber
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

5.  Robot-assisted vs laparoscopic adrenalectomy: a prospective randomized controlled trial.

Authors:  M Morino; G Benincà; G Giraudo; G M Del Genio; F Rebecchi; C Garrone
Journal:  Surg Endosc       Date:  2004-10-26       Impact factor: 4.584

6.  Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism.

Authors:  W T Shen; R C Lim; A E Siperstein; O H Clark; W P Schecter; T K Hunt; J K Horn; Q Y Duh
Journal:  Arch Surg       Date:  1999-06

7.  Robotic versus laparoscopic adrenalectomy in obese patients.

Authors:  Erol Aksoy; Halit Eren Taskin; Shamil Aliyev; Jamie Mitchell; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2012-10-17       Impact factor: 4.584

8.  Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy?

Authors:  Laurent Brunaud; Laurent Bresler; Ahmet Ayav; Rasa Zarnegar; Anne-Laure Raphoz; Than Levan; Georges Weryha; Patrick Boissel
Journal:  Am J Surg       Date:  2008-04       Impact factor: 2.565

9.  Laparoscopic lateral adrenalectomy versus open posterior adrenalectomy for the treatment of benign adrenal tumors.

Authors:  K K J Hallfeldt; T Mussack; A Trupka; F Hohenbleicher; S Schmidbauer
Journal:  Surg Endosc       Date:  2002-10-29       Impact factor: 4.584

10.  Robotic versus laparoscopic adrenalectomy: a comparative study in a high-volume center.

Authors:  Karen Pineda-Solís; Heriberto Medina-Franco; Martin J Heslin
Journal:  Surg Endosc       Date:  2012-09-07       Impact factor: 4.584

View more
  2 in total

Review 1.  Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Magdalena Pisarska; Michał Pędziwiatr; Andrzej Budzyński
Journal:  Gland Surg       Date:  2016-10

Review 2.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.